IP Verse

Pharmaceutical Combinations Of An Angiotensin Receptor Antagonist And An Nep Inhibitor - EP2340828

PATENT ANALYSIS

Patent Details

Grant Date
Jul 15, 2020
Company
NOVARTIS AG
Oppositions

ALFRED E. TIEFENBACHER (GMBH & CO. KG)

BETAPHARM ARZNEIMITTEL GMBH

D YOUNG & CO LLP

GENERICS [UK] LIMITED

KRKA, D.D., NOVO MESTO

SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI

STADA ARZNEIMITTEL AG

ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.

More patents of Novartis Ag

EP3124018

EP3023095

EP3626270

Want to monitor this patent?

Feel free to send us a message here and we will get back to you